Quetiapine for Schizophrenia
Quetiapine (Seroquel - Zeneca), a dibenzothiazepine derivative, has been approved by the FDA for treatment of schizophrenia and other psychotic disorders. It is a new addition to the 'atypical' antipsychotics, which include olanzapine (Zyprexa - Medical Letter, 39:5, 1997), risperidone (Risperdal) and clozapine (Clozaril). Atypical antipsychotic drugs generally are less likely to cause extrapyramidal symptoms than older drugs such as haloperidol (Haldol, and others) or the phenothiazines....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Quetiapine for Schizophrenia
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1016
Article Code: 1016a
Date: December 19, 1997
Volume: 39
Pages: 117-118
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1016
Article Code: 1016a
Date: December 19, 1997
Volume: 39
Pages: 117-118
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)